Immunogenicity persistence of hepatitis A vaccines Healive® and Havrix® among children:15 years follow-up and long-term prediction

Immunogenicity persistence of hepatitis A vaccines Healive® and Havrix® among children:15 years follow-up and long-term prediction

Healive® was the only Chinese WHO-prequalified inactivated vaccine for the hepatitis A virus, which has been widely used in national immunization programs in China. Long-term follow-up studies are needed to estimate the persistence of vaccine-induced antibody levels and the necessity for booster vac...

Full description

Bibliographic Details
Main Authors: Xiaoli Wang, Wenguo Xu, Yuansheng Hu, Hui Yao, Li Xu, Minhua Ma, Ying Zhang, Yalong Wang
Format: Article
Language:English
Published: Taylor & Francis Group 2023-08-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
hepatitis a vaccine
inactivated vaccine
long term follow-up
persistence
immunogenicity
Online Access:http://dx.doi.org/10.1080/21645515.2023.2227549

Internet

http://dx.doi.org/10.1080/21645515.2023.2227549

Similar Items